FDA Inspection 1311208 — Pim Mutsaers, MD
The FDA completed an inspection of Pim Mutsaers, MD on Mar 20, 2026 in Rotterdam. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 20, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Rotterdam (Netherlands)
Additional details
Clinical Investigator (CI)